# Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride

> **NCT02572609** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim**

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Ambroxol hydrochloride soft pastille
- **DRUG:** Mucosolvan ® adult syrup

## Key facts

- **NCT ID:** NCT02572609
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** — (—)
- **Last updated:** 2015-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02572609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02572609, "Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02572609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*